NovaBridge Biosciences NBP
NASDAQ NBP
$1.37 0.00 (-0.36%)
At close: Sep 30, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Revenue (2019 - 2023)

Updated

NovaBridge Biosciences (NBP) reported Revenue of $5,000 for Q4 2023, down 98.4% from the prior quarter.

Analysis

NovaBridge Biosciences (NBP) Revenue (2019 - 2023) Analysis & Trends

For FY2023, NovaBridge Biosciences posted Revenue of $632,000, down 59.3% from FY2022.

  • Revenue has declined for three consecutive years, with a five-year compound annual growth rate of -40.0% (FY2018 to FY2023).
  • By year, Revenue came in at $1.55 million in FY2022 (-88.8%), $13.81 million in FY2021 (-94.2%), $236.42 million in FY2020 and $4.31 million in FY2019 (-47.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 NovaBridge Biosciences 150.88 Mn 150.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 5,000.00
Sep 30, 2023 315,000.00
Jun 30, 2023 159,000.00
Dec 31, 2020 231.27 Mn
Sep 30, 2019 2.14 Mn
API Access

NovaBridge Biosciences Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=NBP&period=max&api_key=YOUR_API_KEY